Skip to main content
. 2022 Jan 20;12:831997. doi: 10.3389/fonc.2022.831997

Figure 7.

Figure 7

Construction and performance validation of the miRNA-30a-5p based nomogram for LUAD patients. Nomogram to predict overall survival (OS) (A), disease-free survival (DFS) (B), and progression-free survival (PFS) (C) for lung cancer patients. The calibration curve and Hosmer–Lemeshow test of nomograms in the TCGA-LUAD cohort for (D) OS, (E) DSS, and (F) PFI.